CytoDyn (CYDY) Enterprise Value (QoQ) (2010 - 2026)
CytoDyn (CYDY) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -214.23% |
| Nov 30, 2025 | 46.61% |
| Aug 31, 2025 | 21.60% |
| May 31, 2025 | 27.42% |
| Feb 28, 2025 | 23.13% |
| Nov 30, 2024 | 14.39% |
| Aug 31, 2024 | -271.73% |
| May 31, 2024 | -377.49% |
| Feb 29, 2024 | -855.10% |
| Nov 30, 2023 | 97.75% |
| Aug 31, 2023 | -157.30% |
| May 31, 2023 | 50.29% |
| Feb 28, 2023 | -2,456.00% |
| Nov 30, 2022 | 95.72% |
| Aug 31, 2022 | -10.52% |
| May 31, 2022 | -323.10% |
| Feb 28, 2022 | 88.73% |
| Nov 30, 2021 | -35.85% |
| Aug 31, 2021 | 80.75% |
| May 31, 2021 | -137.51% |